Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by Tropicalsunon Jan 10, 2023 8:20pm
233 Views
Post# 35214742

RE:Assessment

RE:Assessment
retiredcf wrote:

Added a few more today at $7.32. GLTA

Does the recent acquisition have a significant impact on QIPT"s prospects?


The company acquired (Great Elm) makes sense for QIPT, being a respiratory company with presence in eight states and 270,000 customers. At $80M it is a sizeable deal, but adds $60M in revenue and $13M in EBITDA. There should be $2M in cost savings and it is accretive to cash flow. The market likes the deal. We think it is fine; we might have preferred the vendor take more in shares, to ensure alignment, but on the other hand, a mostly-cash deal is less dilutive. Good earnings growth is expected overall and we think the stock looks decent for a small cap heathcare name. (5iResearch)




retiredcf, the thing that I have always liked about 5iResearch is that they typically don't own the companies that they research. That being said what does it take for these guys to give Kudo's when the company continues to fire on all cylinders.

I would say that most investors, current and potential really like this deal, the markets as well. It's fine doesn't fit the bill and most investors prefer less dilution when ever possible.
<< Previous
Bullboard Posts
Next >>